Expression of RPS25 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPS25 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 1026.36

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

885.6

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2439.6
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2092.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1999.7
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	1803.9
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	1715.2
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1554.8
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1469.0
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1448.4
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1384.9
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1305.6
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1279.5
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1236.4
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1235.2
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	1223.0
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	1213.3
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1202.0
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1172.2
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1167.4
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1154.1
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	1120.7
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	1117.4
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	1104.2
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1102.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1086.8
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	1078.9
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1066.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	1062.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	1058.7
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1058.4
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	1043.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	1042.2
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	1032.8
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	1026.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	987.7
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	986.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	982.7
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	978.9
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	966.5
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	959.1
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	958.9
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	952.7
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	944.2
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	937.5
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	934.9
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	931.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	926.4
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	924.8
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	921.2
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	920.2
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	917.5
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	897.1
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	890.7
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	890.5
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	877.2
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	874.1
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	871.0
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	870.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	869.8
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	865.1
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	863.3
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	862.9
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	848.6
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	847.4
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	845.0
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	842.7
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	841.4
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	835.8
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	835.5
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	831.2
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	823.8
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	823.6
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	823.2
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	808.0
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	802.5
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	798.5
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	791.5
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	791.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	789.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	785.5
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	784.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	772.0
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	771.6
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	770.6
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	763.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	762.5
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	761.8
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	760.4
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	758.1
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	757.0
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	748.2
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	746.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	740.2
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	740.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	733.6
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	725.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	722.7
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	722.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	720.7
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	716.3
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	712.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	711.3
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	708.4
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	706.9
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	706.6
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	704.3
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	698.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	696.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	690.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	685.5
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	670.4
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	665.1
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	663.0
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	658.8
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	658.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	656.9
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	655.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	653.9
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	651.7
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	647.1
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	638.8
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	636.8
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	633.3
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	627.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	627.7
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	626.5
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	622.8
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	620.8
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	620.4
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	612.9
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	594.4
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	593.2
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	588.5
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	556.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	554.6
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	553.2
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	542.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	526.1
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	520.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	494.4
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	467.0
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	414.2
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPS25 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 572.72

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

794.0

Number of samples

Samples

Sample	Description	pTPM
AK213	N, NA, stage:NA, alive, 2010 days	2141.0
AK043	N, NA, stage:NA, alive, 660 days	1794.4
AK066	N, NA, stage:NA, alive, 960 days	1639.8
AK231	N, NA, stage:NA, dead, 240 days	1238.5
AK124	N, NA, stage:NA, alive, 1920 days	1162.5
AK041	N, NA, stage:NA, alive, 810 days	1137.1
AK183	N, NA, stage:NA, alive, 360 days	1112.4
AK142	N, NA, stage:NA, alive, 90 days	1075.5
AK049	N, NA, stage:NA, dead, 180 days	1053.0
AK088	N, NA, stage:NA, dead, 360 days	1026.7
AK072	N, NA, stage:NA, dead, 150 days	1023.5
AK236	N, NA, stage:NA, dead, 360 days	1023.1
AK139	N, NA, stage:NA, dead, 270 days	1000.6
AK156	N, NA, stage:NA, dead, 330 days	991.4
AK165	N, NA, stage:NA, alive, 360 days	975.8
AK199	N, NA, stage:NA, alive, 1860 days	974.4
AK068	N, NA, stage:NA, alive, 360 days	964.9
AK055	N, NA, stage:NA, dead, 240 days	958.8
AK178	N, NA, stage:NA, dead, 240 days	877.2
AK074	N, NA, stage:NA, alive, 300 days	861.9
AK216	N, NA, stage:NA, dead, 360 days	858.0
AK185	N, NA, stage:NA, alive, 330 days	855.0
AK030	N, NA, stage:NA, dead, 120 days	850.6
AK167	N, NA, stage:NA, dead, 180 days	792.5
AK098	N, NA, stage:NA, dead, 660 days	777.1
AK195	N, NA, stage:NA, dead, 390 days	773.4
AK071	N, NA, stage:NA, dead, 540 days	759.2
AK051	N, NA, stage:NA, dead, 360 days	756.3
AK173	N, NA, stage:NA, dead, 180 days	745.9
AK015	N, NA, stage:NA, alive, 720 days	727.8
AK158	N, NA, stage:NA, dead, 360 days	724.6
AK053	N, NA, stage:NA, dead, 300 days	721.7
AK002	N, NA, stage:NA, dead, 570 days	720.7
AK003	N, NA, stage:NA, dead, 600 days	720.1
AK102	N, NA, stage:NA, alive, 1740 days	707.7
AK133	N, NA, stage:NA, dead, 360 days	666.3
AK188	N, NA, stage:NA, alive, 420 days	652.8
AK205	N, NA, stage:NA, dead, 120 days	635.1
AK149	N, NA, stage:NA, dead, 420 days	629.6
AK153	N, NA, stage:NA, dead, 240 days	621.8
AK103	N, NA, stage:NA, alive, 1320 days	595.6
AK100	N, NA, stage:NA, alive, 960 days	573.2
AK091	N, NA, stage:NA, dead, 210 days	572.2
AK117	N, NA, stage:NA, dead, 210 days	559.5
AK089	N, NA, stage:NA, dead, 330 days	552.9
AK085	N, NA, stage:NA, alive, 660 days	534.1
AK227	N, NA, stage:NA, alive, 300 days	532.3
AK035	N, NA, stage:NA, dead, 210 days	496.4
AK099	N, NA, stage:NA, dead, 420 days	449.0
AK079	N, NA, stage:NA, dead, 210 days	436.1
AK134	N, NA, stage:NA, dead, 360 days	433.5
AK081	N, NA, stage:NA, dead, 180 days	425.3
AK076	N, NA, stage:NA, alive, 660 days	421.4
AK005	N, NA, stage:NA, dead, 240 days	400.3
AK218	N, NA, stage:NA, dead, 180 days	371.9
AK006	N, NA, stage:NA, dead, 360 days	340.6
AK123	N, NA, stage:NA, dead, 180 days	329.1
AK226	N, NA, stage:NA, dead, 360 days	300.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0127480003	Tumor	0.7
CPT0217430008	Tumor	0.7
CPT0168080003	Tumor	0.7
CPT0182580003	Tumor	0.6
CPT0218830004	Tumor	0.6
CPT0224390004	Tumor	0.6
CPT0218330004	Tumor	0.6
CPT0217190003	Tumor	0.6
CPT0206000004	Tumor	0.6
CPT0217100003	Tumor	0.5
CPT0093510003	Tumor	0.4
CPT0206230003	Tumor	0.4
CPT0225760003	Tumor	0.4
CPT0228220003	Tumor	0.4
CPT0217710008	Tumor	0.4
CPT0168830003	Tumor	0.3
CPT0123530003	Tumor	0.3
CPT0093450003	Tumor	0.3
CPT0205450004	Tumor	0.2
CPT0161730003	Tumor	0.2
CPT0217880003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0206560003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0206670004	Tumor	0.2
CPT0225730003	Tumor	0.2
CPT0218690004	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0189750004	Tumor	0.2
CPT0093590003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0171580008	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0079790003	Tumor	0.1
CPT0224600003	Tumor	0.1
CPT0207090003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0087680003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0224330003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0205780003	Tumor	0.0
CPT0125510003	Tumor	0.0
CPT0167970003	Tumor	0.0
CPT0205670004	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0201710003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0218960004	Tumor	0.0
CPT0224540004	Tumor	-0.1
CPT0206780003	Tumor	-0.1
CPT0199770003	Tumor	-0.1
CPT0216920008	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0168590003	Tumor	-0.1
CPT0182500003	Tumor	-0.1
CPT0206330003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0190360004	Tumor	-0.2
CPT0167530003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0208980003	Tumor	-0.2
CPT0093550003	Tumor	-0.2
CPT0087730003	Tumor	-0.2
CPT0189570004	Tumor	-0.2
CPT0168380003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0219080004	Tumor	-0.2
CPT0204400003	Normal	-0.3
CPT0189850004	Tumor	-0.3
CPT0175060003	Tumor	-0.3
CPT0167750004	Tumor	-0.3
CPT0218670003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0189650004	Tumor	-0.4
CPT0204390003	Normal	-0.4
CPT0104330003	Tumor	-0.4
CPT0064650003	Tumor	-0.4
CPT0204370003	Normal	-0.4
CPT0087570003	Tumor	-0.4
CPT0168720003	Tumor	-0.4
CPT0206880003	Tumor	-0.5
CPT0204340003	Normal	-0.5
CPT0204330003	Normal	-0.5
CPT0204380003	Normal	-0.5
CPT0186100003	Tumor	-0.5
CPT0217000004	Tumor	-0.5
CPT0125570003	Tumor	-0.5
CPT0204360003	Normal	-0.6
CPT0087950003	Tumor	-0.6
CPT0218770003	Tumor	-0.6
CPT0162020003	Tumor	-0.6
CPT0206450003	Tumor	-0.6
CPT0204410003	Normal	-0.6
CPT0204420003	Normal	-0.7
CPT0189460003	Tumor	-0.7
CPT0190240004	Tumor	-0.7
CPT0204350003	Normal	-0.7
CPT0205890003	Tumor	-0.8
CPT0189250003	Tumor	-0.9
CPT0196850003	Tumor	-0.9
CPT0104220003	Tumor	-1.0
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA031801
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade
Glioma, malignant, High grade Glioblastoma, NOS